March 21, 2019 10:04 AM EDT
Financing
R&D

Brex­it who? Record in­vest­ment last year fu­els big spike in reg­is­tered UK biotech firms

Natalie Grover

Reporter

LON­DON — Af­ter Britain nar­row­ly signed up to leave the Eu­ro­pean Union in June 2016, the prog­no­sis for in­dus­try was pro­ject­ed to be grim. A new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Out­look's shares crash as wet AMD drug flunks Phase 3 test

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

A service from the Financial Times